@article{658068b0437747f0a0c40b9882b50664,
title = "High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?",
abstract = "N/A",
keywords = "Botulinum Toxins, Type A, Dose-Response Relationship, Drug, Humans, Muscle Spasticity, Neuromuscular Agents, Pharmacology, Stroke, Toxicology, Upper motor neuron syndrome, adverse effects, botulinum toxin type A, incobotulinumtoxinA, safety, spasticity, stroke, Botulinum Toxins, Type A, Dose-Response Relationship, Drug, Humans, Muscle Spasticity, Neuromuscular Agents, Pharmacology, Stroke, Toxicology, Upper motor neuron syndrome, adverse effects, botulinum toxin type A, incobotulinumtoxinA, safety, spasticity, stroke",
author = "Andrea Santamato and Maurizio Ranieri and Vincenzo Solfrizzi and Madia Lozupone and Michele Vecchio and Antonio Daniele and Antonio Greco and Davide Seripa and Giancarlo Logroscino and Francesco Panza",
year = "2016",
doi = "10.1080/17425255.2016.1198318",
language = "English",
volume = "12",
pages = "843--846",
journal = "Expert Opinion on Drug Metabolism and Toxicology",
issn = "1742-5255",
publisher = "Informa Healthcare",
}